Non-Invasive Skin Genomics for Pharma Partners
Precision Biomarker Platform Technology
- Enabled by DermTech’s proprietary non-invasive Smart Sticker® skin sample collection platform
- Useful for genomic and other analyses of lesional and non-lesional skin samples to guide drug development
- Ideal for indications where skin is the target or surrogate target organ
- Trusted by 300,000+ patients, 3,000+ clinicians, 30+ pharma and research partners
Industry Partners Use the Stratum Platform for:
Stratification and selection of patients based on gene expression profiles
Biomarker identification of specific diseases and disease subsets
Tracking and prediction of drug response (before/ after dosing)
New target identification
Development of complementary and companion diagnostics
Disease characterization and phenotyping
Tissue bank available of over 10,000 non-invasively obtained skin samples from numerous inflammatory skin conditions and skin cancers.
RNA Analyses
DNA Analyses
Protein Analyses
The Smart Sticker platform has been used for numerous indications:
Send us a message
Click the contact us button and drop us a line. We’ll be in touch shortly.
Get In Touch
Partner with Stratum by DermTech 2.0.